Health Care: Drugs

Acura Pharmaceuticals Inc (ACUR: NASDAQ)

$0.94 0.03 | 3.3%
06/29/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 751.00K 123.00K 0.00 20.47M
Cost of Sales 227.00K 114.00K 0.00 0.00
Gross Operating Profit 524.00K 9.00K 0.00 20.47M
Selling, General, and Administrative Expenses 7.94M 8.93M 6.01M 5.90M
Research & Development 4.58M 4.92M 3.73M 4.04M
Operating Income before D & A (EBITDA) -12.00M -13.84M -9.74M 10.53M
Depreciation & Amortization 712.00K 134.00K 131.00K 131.00K
Interest Income 0.00 0.00 79.00K 32.00K
Other Income - Net 202.00K 198.00K -8.00K -34.00K
Special Income / Charges -201.00K -250.00K 0.00 0.00
Total Income Before Interest Expenses (EBIT) -12.71M -14.03M -9.80M 10.40M
Interest Expense 1.21M 9.00K 0.00 0.00
Pre-Tax Income -13.92M -14.04M -9.80M 10.40M
Income Taxes 0.00 0.00 0.00 147.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -13.21M -13.90M -9.67M 10.38M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -13.21M -13.90M -9.67M 10.38M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -13.21M -13.90M -9.67M 10.38M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-13.01M -13.65M -9.67M 10.38M
Preferred Dividends
Net Income Available To Common -13.21M -13.90M -9.67M 10.38M
Basic EPS from Continuing Ops. -0.27 -0.29 -0.20 0.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.27 -0.29 -0.20 0.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.27 -0.29 -0.20 0.22
Basic Normalized Net Income/Share -0.27 -0.29 -0.20 0.22
EPS fr Continuing Ops. -0.27 -0.29 -0.20 0.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.27 -0.29 -0.20 0.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.27 -0.29 -0.20 0.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.27 -0.29 -0.20 0.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACUR

Latest ACUR Headlines from TheStreet

More Financial News for ACUR

Press Releases for ACUR

See All Press Releases

Partner Headlines for ACUR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter